Welcome to our dedicated page for Almonty Industri SEC filings (Ticker: ALM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Almonty Industri's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Almonty Industri's regulatory disclosures and financial reporting.
Almonty Industries Inc. furnished a Form 6-K that lists two exhibits: CEO and CFO certifications of interim filings. The exhibits are identified as Exhibit 99.1 (CEO) and Exhibit 99.2 (CFO), reflecting the company’s submission of officer certifications under Canadian Form 52-109F2.
Almonty Industries Inc. filed an amended Form F-10 base shelf to register up to US$500,000,000 of securities, to be offered from time to time during a 25‑month period after effectiveness. The shelf covers Common Shares, Preferred Shares, Debt Securities, Warrants, Subscription Receipts, and Units, with specific terms to be set by future prospectus supplements.
Offerings may be primary by the company and may also include sales by selling securityholders. Distribution methods include underwriters, dealers, agents, or direct sales at fixed, market, or negotiated prices, and may permit over‑allotments. Unless stated in a supplement, securities other than Common Shares are not expected to be listed.
Almonty’s Common Shares trade on the TSX (AII), Nasdaq (ALM), ASX as CDIs (AII), and the Frankfurt Stock Exchange (ALI1). The filing uses Canadian disclosure standards under the multijurisdictional system and IFRS, and includes extensive risk and forward‑looking statements cautionary language typical for a shelf program.
Almonty Industries Inc. furnished a Form 6-K announcing that it filed a preliminary base shelf prospectus. The filing includes Exhibit 99.1, a press release dated October 22, 2025, titled “Almonty Announces Filing of Preliminary Base Shelf Prospectus.”
The report was signed by Chairman, President, Chief Executive Officer and Director Lewis Black. This is an administrative disclosure that signals preparation for potential future securities offerings under a shelf framework, but this excerpt does not state specific offering amounts or terms.
Almonty Industries Inc. filed a preliminary short form base shelf prospectus on Form F‑10 under the multijurisdictional disclosure system, allowing it to offer, issue and sell Common Shares, Preferred Shares, Debt Securities, Warrants, Subscription Receipts and Units from time to time after effectiveness. Specific terms, pricing and amounts will be set in future prospectus supplements, which will also identify any underwriters, fees and the applicable distribution method.
The shelf also permits one or more selling securityholders to offer securities, with sales potentially conducted through underwriters, dealers, agents or directly. Securities other than Common Shares are not expected to be listed unless specified in a supplement, which may affect liquidity and pricing. Almonty’s Common Shares trade on the TSX (AII), Nasdaq (ALM), ASX (AII CDIs) and FSE (ALI1); on October 21, 2025, closing prices were C$11.67 on the TSX and US$8.24 on Nasdaq.
The company effected a 1.5‑to‑1 share consolidation in July 2025. As of the date of this prospectus, 230,928,191 Common Shares were outstanding, alongside outstanding Warrants, Options and RSUs as disclosed. Risk factors and earnings coverage, where required, will be detailed in applicable supplements.